Cargando…
Ozone adjunct treatment in facing multidrug‐resistant bacteria?
Autores principales: | Chirumbolo, Salvatore, Valdenassi, Luigi, Franzini, Marianno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585054/ https://www.ncbi.nlm.nih.gov/pubmed/37867538 http://dx.doi.org/10.1002/ccr3.8087 |
Ejemplares similares
-
The need for a correct oxygen-ozone autohemotherapy (O(3)-AHT) in patients with mild to moderate COVID-19 pneumonia
por: Chirumbolo, Salvatore, et al.
Publicado: (2021) -
Comments on the optimal use of medical ozone in clinics versus the Ozone High Dose Therapy (OHT) approach
por: Franzini, Marianno, et al.
Publicado: (2022) -
The Role of Ozone as an Nrf2-Keap1-ARE Activator in the Anti-Microbial Activity and Immunity Modulation of Infected Wounds
por: Franzini, Marianno, et al.
Publicado: (2023) -
Insights on the mechanisms of action of ozone in the medical therapy against COVID-19
por: Chirumbolo, Salvatore, et al.
Publicado: (2021) -
Male vs. Female Differences in Responding to Oxygen–Ozone Autohemotherapy (O(2)-O(3)-AHT) in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
por: Chirumbolo, Salvatore, et al.
Publicado: (2021)